These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 19015958)
41. Molecular therapy in support to radiotherapy. Dutreix M; Cosset JM; Sun JS Mutat Res; 2010; 704(1-3):182-9. PubMed ID: 20067843 [TBL] [Abstract][Full Text] [Related]
42. The role of gene therapy in regenerative surgery: updated insights. Giatsidis G; Venezia ED; Bassetto F Plast Reconstr Surg; 2013 Jun; 131(6):1425-1435. PubMed ID: 23714802 [TBL] [Abstract][Full Text] [Related]
43. Nanoscale microenvironment engineering based on layer-by-layer self-assembly to regulate hair follicle stem cell fate for regenerative medicine. Chen P; Miao Y; Zhang F; Huang J; Chen Y; Fan Z; Yang L; Wang J; Hu Z Theranostics; 2020; 10(25):11673-11689. PubMed ID: 33052240 [TBL] [Abstract][Full Text] [Related]
44. Cell-Free Approaches and Therapeutic Biomolecules for Cardiac Regeneration. Gyöngyösi M Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33530565 [TBL] [Abstract][Full Text] [Related]
45. Antisense oligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases. Tomita N; Morishita R Curr Pharm Des; 2004; 10(7):797-803. PubMed ID: 15032704 [TBL] [Abstract][Full Text] [Related]
46. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice. Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233 [TBL] [Abstract][Full Text] [Related]
54. Knocking down gene expression with dendritic vectors. Raviña M; Paolicelli P; Seijo B; Sanchez A Mini Rev Med Chem; 2010 Jan; 10(1):73-86. PubMed ID: 20380642 [TBL] [Abstract][Full Text] [Related]
55. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo. Kunze D; Wuttig D; Kausch I; Blietz C; Blumhoff L; Burmeister Y; Kraemer K; Fuessel S; Toma M; Schwenzer B; Meye A; Grimm MO; Hakenberg OW; Jocham D; Wirth MP Int J Oncol; 2008 May; 32(5):1049-56. PubMed ID: 18425331 [TBL] [Abstract][Full Text] [Related]
56. Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes. Capi O; Gepstein L J Control Release; 2006 Nov; 116(2):211-8. PubMed ID: 17005287 [TBL] [Abstract][Full Text] [Related]
57. Targeting human telomerase by antisense oligonucleotides and ribozymes. Folini M; Pennati M; Zaffaroni N Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):605-12. PubMed ID: 12678727 [TBL] [Abstract][Full Text] [Related]
58. [Therapeutic oligonucleotides: a review]. Wang X; Xian J; Chen G; Peng H Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):664-675. PubMed ID: 29893074 [TBL] [Abstract][Full Text] [Related]
59. Antisense inhibition: oligonucleotides, ribozymes, and siRNAs. Zhang YC; Taylor MM; Samson WK; Phillips MI Methods Mol Med; 2005; 106():11-34. PubMed ID: 15375310 [No Abstract] [Full Text] [Related]